Publications by authors named "Asem Mohammed Albeshri"

Synopsis of recent research by authors named "Asem Mohammed Albeshri"

  • - Asem Mohammed Albeshri's recent research primarily focuses on the efficacy of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in combination with endocrine therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer.
  • - The study, conducted at two cancer centers in Saudi Arabia, demonstrated a significant improvement in progression-free survival and overall survival among patients who received palbociclib alongside endocrine therapy compared to those who only received endocrine therapy.
  • - This work underscores the potential benefits of integrating targeted therapies into treatment regimens for advanced breast cancer, highlighting valuable local clinical experiences and data from Saudi Arabia that contribute to the global understanding of breast cancer treatment options.